Company / Share Buybacks
Caris Life Sciences, Inc. Share Buybacks History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$113.0K
FY2025
5-year range
$0 / $113.0K
FY2023-FY2025
Trend
-
vs FY2024
Sector context
#87 of 101
Health Care
What the data says
Caris Life Sciences, Inc.'s share buybacks of $113,000 is lower than 86% of companies in the Health Care sector (FY2025). Improved from $0 to $113,000 over the past 2 years.
Based on SEC 10-K filings.
$113,000 in FY2025.
Improved from $0 to $113,000 over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 101This company $113.0K Sector average $570.7M
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #87 out of 101 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.0K | - |
| FY2024 | $0 | - |
| FY2023 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026